By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fujisawa GmbH 

Neumarkter Str. 61

Munich    D-81673  Germany
Phone: 49-89-45-44-06 Fax: 49-89-45-44-21-20


Drug Discovery

Company News
Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago10/19/2005 5:13:11 PM
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval10/19/2005 5:13:03 PM
Gloucester Pharmaceuticals, Inc. Initiates Pivotal Trial With FK228 In Cutaneous T-Cell Lymphoma; FDA Approves Trial Protocol Under Special Protocol Assessment10/19/2005 5:12:52 PM
Cardiome Pharma Corp.'s (COM.TO) Pivotal AF Study Achieves Primary Endpoint10/19/2005 5:12:30 PM
Phase Forward Partners With Fujitsu To Promote InForm EDC Solution In Japan10/19/2005 5:11:42 PM
Fujisawa Pharmaceutical Co., Ltd. And Yamanouchi Pharmaceutical Co., Ltd. Will Establish Zepharma Inc., An OTC Pharmaceutical Company10/19/2005 5:11:27 PM
Evotec OAI (Germany) (DX:EVT) Enters Into Integrated Virtual Screening And Medicinal Chemistry Agreement With Fujisawa Pharmaceutical Co., Ltd.10/19/2005 5:10:52 PM
American Pharmaceutical Partners (APPX) Receives Approval For Adenosine10/19/2005 5:10:45 PM
Atrix Laboratories, Inc. (ATRX) And Fujisawa Healthcare Submit New Drug Application For Acne Product10/19/2005 5:10:29 PM
Hemispherx Biopharma (HEB) Signs Option Agreement For Ampligen With Fujisawa Pharmaceutical Co., Ltd.10/19/2005 5:10:02 PM